1. Energy Crisis Links to Autophagy and Ferroptosis in Alzheimer’s Disease: Current Evidence and Future Avenues
   Yong-Gang Fan et al, 2023, Current Neuropharmacology CrossRef
2. Elevated levels of cerebrospinal fluid neuron-specific enolase (NSE) in Alzheimer's disease
   Frank Martin Schmidt et al, 2014, Neuroscience Letters CrossRef
3. The beneficial effect of exercise against Alzheimer's disease may result from improved brain glucose metabolism
   Na Zhao et al, 2021, Neuroscience Letters CrossRef
4. Alzheimer amyloid-β- peptide disrupts membrane localization of glucose transporter 1 in astrocytes: implications for glucose levels in brain and blood
   Rachel D. Hendrix et al, 2021, Neurobiology of Aging CrossRef
5. A Systematic Review of Glucose Transport Alterations in Alzheimer's Disease
   Natalia Kyrtata et al, 2021, Frontiers in Neuroscience CrossRef
6. Long-term oral galactose treatment prevents cognitive deficits in male Wistar rats treated intracerebroventricularly with streptozotocin
   Melita Salkovic-Petrisic et al, 2014, Neuropharmacology CrossRef
7. 7,8-Dihydroxyflavone Ameliorates Scopolamine-Induced Alzheimer-Like Pathologic Dysfunction
   Chong Chen et al, 2014, Rejuvenation Research CrossRef
8. Quantitative Proteomic Analysis of the Orbital Frontal Cortex in Rats Following Extended Exposure to Caffeine Reveals Extensive Changes to Protein Expression: Implications for Neurological Disease
   Jane L. Franklin et al, 2016, Journal of Proteome Research CrossRef
9. Dysfunctional Glucose Metabolism in Alzheimer’s Disease Onset and Potential Pharmacological Interventions
   Vijay Kumar et al, 2022, International Journal of Molecular Sciences CrossRef
10. Cognitive, behavioral and metabolic effects of oral galactose treatment in the transgenic Tg2576 mice
    Ana Babic Perhoc et al, 2019, Neuropharmacology CrossRef
11. Expression of glucose transporters in human neurodegenerative diseases
    Kinga Głuchowska et al, 2021, Biochemical and Biophysical Research Communications CrossRef
12. INSULIN AND INSULIN RESISTANCE: NEW MOLECULE MARKERS AND TARGET MOLECULE FOR THE DIAGNOSIS AND THERAPY OF DISEASES OF THE CENTRAL NERVOUS SYSTEM
    A. B. Salmina et al, 2013, Bulletin of Siberian Medicine CrossRef
13. Scavenging Reactive Oxygen Species Decreases Amyloid-β Levels via Activation of PI3K/Akt/GLUT1 Pathway in N2a/APP695swe Cells
    Yan Peng et al, 2022, Journal of Alzheimer's Disease CrossRef
14. Glucose Transporters in Brain: In Health and in Alzheimer’s Disease
    Leszek Szablewski, 2016, Journal of Alzheimer's Disease CrossRef